Nynikka R Palmer1, Steven E Gregorich2, Jennifer Livaudais-Toman2, Jane Jih2, Celia P Kaplan2. 1. Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, 1001 Potrero Avenue, Building 10, 3rd Floor, UCSF Box 1364, San Francisco, CA, 94143, USA. nynikka.palmer@ucsf.edu. 2. Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Abstract
OBJECTIVE: We examined prostate cancer patients' perceived engagement in treatment decision-making and associated factors by race/ethnicity in a multiethnic sample. METHOD: We identified patients through the California Cancer Registry. Patients completed a cross-sectional telephone interview in English, Spanish, Cantonese, or Mandarin. Multivariable logistic regression models, stratified by race/ethnicity, estimated the associations of patient demographic and health status characteristics on (1) doctor asked patient to help decide treatment plan and (2) patient and doctor worked out a treatment plan together. RESULTS: We included 855 prostate cancer patients: African American (19%), Asian American (15%), Latino (24%), and White (42%). Asian American patients were less likely than White patients to report that their doctors asked them to help decide a treatment plan (OR = 0.31; 95% CI = 0.18-0.53) and that they worked out a treatment plan with their doctors (OR = 0.54; 95% CI = 0.33-0.90). Language of interview was a significant contributing factor in stratified analysis for both outcomes. CONCLUSION: Asian American prostate cancer patients reported less engagement in treatment decision-making, with Chinese language being a significant contributing factor. Future research should identify patient-centered strategies that effectively engage underserved patients and support healthcare providers in shared decision-making with multiethnic and multilingual patients.
OBJECTIVE: We examined prostate cancer patients' perceived engagement in treatment decision-making and associated factors by race/ethnicity in a multiethnic sample. METHOD: We identified patients through the California Cancer Registry. Patients completed a cross-sectional telephone interview in English, Spanish, Cantonese, or Mandarin. Multivariable logistic regression models, stratified by race/ethnicity, estimated the associations of patient demographic and health status characteristics on (1) doctor asked patient to help decide treatment plan and (2) patient and doctor worked out a treatment plan together. RESULTS: We included 855 prostate cancer patients: African American (19%), Asian American (15%), Latino (24%), and White (42%). Asian American patients were less likely than White patients to report that their doctors asked them to help decide a treatment plan (OR = 0.31; 95% CI = 0.18-0.53) and that they worked out a treatment plan with their doctors (OR = 0.54; 95% CI = 0.33-0.90). Language of interview was a significant contributing factor in stratified analysis for both outcomes. CONCLUSION: Asian American prostate cancer patients reported less engagement in treatment decision-making, with Chinese language being a significant contributing factor. Future research should identify patient-centered strategies that effectively engage underserved patients and support healthcare providers in shared decision-making with multiethnic and multilingual patients.
Authors: Eva Johansson; Gunnar Steineck; Lars Holmberg; Jan-Erik Johansson; Tommy Nyberg; Mirja Ruutu; Anna Bill-Axelson Journal: Lancet Oncol Date: 2011-08-05 Impact factor: 41.316
Authors: Neda Ratanawongsa; Brian J Zikmund-Fisher; Mick P Couper; John Van Hoewyk; Neil R Powe Journal: Med Decis Making Date: 2010 Sep-Oct Impact factor: 2.583
Authors: Stephen A Boorjian; R Jeffrey Karnes; Rosalia Viterbo; Laureano J Rangel; Eric J Bergstralh; Eric M Horwitz; Michael L Blute; Mark K Buyyounouski Journal: Cancer Date: 2011-01-10 Impact factor: 6.860
Authors: Nancy L Keating; Edward Guadagnoli; Mary Beth Landrum; Catherine Borbas; Jane C Weeks Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 44.544
Authors: Erin L Mead; Ardith Z Doorenbos; Sara H Javid; Emily A Haozous; Lori Arviso Alvord; David R Flum; Arden M Morris Journal: Am J Public Health Date: 2013-10-17 Impact factor: 9.308
Authors: Joaquin Michel; Jorge Ballon; Sarah E Connor; David C Johnson; Jonathan Bergman; Christopher S Saigal; Mark S Litwin; Dana L Alden Journal: MDM Policy Pract Date: 2021-05-27
Authors: Nynikka R Palmer; Hala T Borno; Steven E Gregorich; Jennifer Livaudais-Toman; Celia P Kaplan Journal: Cancer Causes Control Date: 2021-06-29 Impact factor: 2.532